Private-equity-backed Swedish biopharmaceutical company Aprea Therapeutics has raised a €50m series-C funding round led by Redmile Group, a US-based VC firm focused on healthcare.
Vehicle is expected to hold a final close in March 2020, Unquote understands
Merger of German and Dutch peers will result in a client base of 3,500 companies
Fund's predecessor, BlackFin Financial Services Fund II, closed on €400m in 2016
GP will support the Munich-based software company's growth by broadening its product offering